Recent steps by FDA to promote the use of real-world evidence are to be commended, but the future demands a broader vision that makes greater use of growing sources of health care information.
Brad Jordan, PhD
Advertisement
Articles by Brad Jordan, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week
2
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
3
Impact of Automated Insulin Delivery on Type 2 Diabetes Measures
4
Dermatology Practices Absorb Rising Prior Authorization Costs
5